Triumph Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Sell |
4,643
-283
| -6% | -$35.8K | 0.18% | 142 |
|
|
2025
Q1 | $630K | Sell |
4,926
-121
| -2% | -$15.5K | 0.21% | 127 |
|
|
2024
Q4 | $667K | Buy |
5,047
+187
| +4% | +$24.7K | 0.23% | 111 |
|
|
2024
Q3 | $708K | Buy |
4,860
+1,634
| +51% | +$238K | 0.25% | 99 |
|
|
2024
Q2 | $443K | Sell |
3,226
-553
| -15% | -$75.9K | 0.17% | 140 |
|
|
2024
Q1 | $517K | Sell |
3,779
-84
| -2% | -$11.5K | 0.21% | 113 |
|
|
2023
Q4 | $525K | Sell |
3,863
-220
| -5% | -$29.9K | 0.22% | 94 |
|
|
2023
Q3 | $499K | Buy |
4,083
+35
| +0.9% | +$4.28K | 0.23% | 102 |
|
|
2023
Q2 | $514K | Sell |
4,048
-360
| -8% | -$45.7K | 0.23% | 94 |
|
|
2023
Q1 | $569K | Sell |
4,408
-922
| -17% | -$119K | 0.29% | 61 |
|
|
2022
Q4 | $700K | Sell |
5,330
-12,720
| -70% | -$1.67M | 0.37% | 59 |
|
|
2022
Q3 | $2.11M | Sell |
18,050
-5,060
| -22% | -$592K | 1.15% | 22 |
|
|
2022
Q2 | $2.72M | Buy |
23,110
+8,482
| +58% | +$998K | 1.44% | 15 |
|
|
2022
Q1 | $1.91M | Buy |
+14,628
| New | +$1.91M | 0.83% | 25 |
|